person
Jean-Sebastien F.
- Country
- France
- Department
- Medical Oncology
Research Overview
assignment
62
Clinical Trials ·
- Evaluation of AZD2014 and Anastrozole in Metastatic Hormone Receptor-Positive Endometrial Adenocarcinoma: A Phase I/II Multicentric, Randomized, Open-Label Study
- A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
- Phase 1 Dose Escalation and Cohort Expansion Study of Anti-PD-1 Monoclonal Antibody TSR-042 in Advanced Solid Tumors
location_city
6
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
466
Sites with multiple studies
Has run more than one trial at 466 of 767 partner sites.
Specializations
Breast Cancer Research
Specializes in investigating advanced therapeutic approaches for various breast cancer subtypes, including hormone receptor-positive (HR+), HER2-negative, and triple-negative breast cancer.
- Advanced hormone therapy combinations
- Novel targeted therapies
- Immunotherapy approaches
Gynecologic Oncology
Focuses on developing treatments for ovarian cancer, endometrial cancer, and cervical cancer, with particular emphasis on advanced and recurrent disease states.
- Platinum-resistant disease
- Maintenance therapy strategies
- Targeted molecular approaches
Precision Medicine
Investigates biomarker-driven therapies and molecular-based treatment approaches across various solid tumors.
- Antibody-drug conjugates
- Molecular targeting agents
- Personalized treatment strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.